RP-HPLC as an evaluation method for the behaviour of urinary trypsin inhibitors

1988 ◽  
Vol 26 (1) ◽  
pp. 369-371 ◽  
Author(s):  
G. Raspi ◽  
A. Lo Moro ◽  
M. Spinetti ◽  
M. Molinari
1989 ◽  
Vol 335 (4) ◽  
pp. 398-401
Author(s):  
Giorgio Raspi ◽  
Antonio Lo Moro ◽  
Maria Spinetti ◽  
Marica Molinari

2006 ◽  
Vol 24 (1) ◽  
pp. 5-15 ◽  
Author(s):  
Michael J. Pugia ◽  
Saeed A. Jortani ◽  
Manju Basu ◽  
Ronald Sommer ◽  
Hai-Hang Kuo ◽  
...  

1977 ◽  
Author(s):  
A. Takada ◽  
Y. Takada ◽  
K. Minakata ◽  
H. Sumi

Human urine was passed through Celite 545 column, and the non adsorbed eluate was adsorbed to Bentnite, then eluted with 2 % pyridine. The eluate was precipitated with ammonia sulfate, and the precipitate was dissolved, then passed through DEAE-Sephadex A-50, trypsin-Sepharose and Sephadex G-200. There were three types of urinary trypsin inhibitors (UTI) of m.w. of 69,000, 45,000, and 25,000 respectively. No difference in inhibitory spectra was observed among these three UTI’s. Purified UTI inhibited trypsin, chymotrypsin, and kallikrein. The inhibition of chymotrypsin did not exceed 50even at the high concentration of UTI. UTI inhibited plasmin to a lesser extent but no inhibition of thrombin, Cls, Clr or urokinase was observed.UTI had 7% carbohydrate and no HIS, PRO, or TRP was found in aminoacid analysis. UTI was not identical to α1A but related to inter α- trypsin inhibitor immunologically. Some persons excreted both UTI and α1A in the urine although most people did only UTI. Since α1A is not found in the urine of most people, UTI may not be the same as inter α-trypsin inhibitor which is filtered into the urine.


Cardiology ◽  
2009 ◽  
Vol 114 (4) ◽  
pp. 264-270 ◽  
Author(s):  
Seok J. Kim ◽  
Kyung Y. Yoo ◽  
Cheol W. Jeong ◽  
Woong M. Kim ◽  
Hyung K. Lee ◽  
...  

1970 ◽  
Vol 56 (2) ◽  
pp. 71-81
Author(s):  
Gerda Mootse ◽  
Domenico Agostino ◽  
Eugene E. Cliffton

Growth of a transplanted Walker 256 carcinosarcoma in rats was accompanied by: 1) An increase in plasma fibrinogen and urinary trypsin inhibitors; 2) A significant decrease in plasma plasminogen and hematocrit; 3) A decrease in urokinase activity in urine; 4) A decrease in fibrinolytic activity of the euglobulin fraction of plasma and serum. There was no significant change in the plasma inhibitors for trypsin or bovine fibrinolysin.


2005 ◽  
Vol 43 (1) ◽  
pp. 1-16 ◽  
Author(s):  
Michael J. Pugia ◽  
John A. Lott

AbstractInflammation is an important indicator of tissue injury. In the acute form, there is usually accumulation of fluids and plasma components in the affected tissues. Platelet activation and the appearance in blood of abnormally increased numbers of polymorphonucleocytes, lymphocytes, plasma cells and macrophages usually occur. Infectious disorders such as sepsis, meningitis, respiratory infection, urinary tract infection, viral infection, and bacterial infection usually induce an inflammatory response. Chronic inflammation is often associated with diabetes mellitus, acute myocardial infarction, coronary artery disease, kidney diseases, and certain auto-immune disorders, such as rheumatoid arthritis, organ failures and other disorders with an inflammatory component or etiology. The disorder may occur before inflammation is apparent. Markers of inflammation such as C-reactive protein (CRP) and urinary trypsin inhibitors have changed our appraisal of acute events such as myocardial infarction; the infarct may be a response to acute infection and (or) inflammation.We describe here the pathophysiology of an anti-inflammatory agent termed urinary trypsin inhibitor (uTi). It is an important anti-inflammatory substance that is present in urine, blood and all organs. We also describe the anti-inflammatory agent bikunin, a selective inhibitor of serine proteases. The latter are important in modulating inflammatory events and even shutting them down.


Author(s):  
T. Oikawa ◽  
H. Kosugi ◽  
F. Hosokawa ◽  
D. Shindo ◽  
M. Kersker

Evaluation of the resolution of the Imaging Plate (IP) has been attempted by some methods. An evaluation method for IP resolution, which is not influenced by hard X-rays at higher accelerating voltages, was proposed previously by the present authors. This method, however, requires truoblesome experimental preperations partly because specially synthesized hematite was used as a specimen, and partly because a special shape of the specimen was used as a standard image. In this paper, a convenient evaluation method which is not infuenced by the specimen shape and image direction, is newly proposed. In this method, phase contrast images of thin amorphous film are used.Several diffraction rings are obtained by the Fourier transformation of a phase contrast image of thin amorphous film, taken at a large under focus. The rings show the spatial-frequency spectrum corresponding to the phase contrast transfer function (PCTF). The envelope function is obtained by connecting the peak intensities of the rings. The evelope function is offten used for evaluation of the instrument, because the function shows the performance of the electron microscope (EM).


Sign in / Sign up

Export Citation Format

Share Document